Article Details

Yingli Pharma gains FDA approval for Phase III trial of r/r PTCL drug candidate

Retrieved on: 2025-04-02 17:03:31

Tags for this article:

Click the tags to see associated articles and topics

Yingli Pharma gains FDA approval for Phase III trial of r/r PTCL drug candidate. View article details on hiswai:

Excerpt

The gold standard of business intelligence. Find out more. The global registration trial is due to begin in the second quarter of this year and ...

Article found on: www.clinicaltrialsarena.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up
Book a Demo